YAP1 and cancer: Although initial investigations suggested that depletion of LATS1/2 (thus activating YAP/TAZ) enhances cancer immunity [219], a growing body of evidence now supports that, on the whole, YAP/TAZ function as suppressors of antitumor immunity [220].